Teijin Studies Renal Indication For Gout Drug
This article was originally published in PharmAsia News
Executive Summary
Teijin Pharma Ltd is collaborating with Japanese academia and medical facilities to develop gout treatment Feburic (febuxostat) for chronic renal disorders and metabolism syndrome, said the company.